
Tuesday, September 15, 2020 9:39:53 AM
Dear Friend;
It has been a long time coming but we are back! or almost there as you will read in the attached news release. Here is some background:
1. The Company asked to have its stock halted December 12, 2019 - we were NOT suspended by the Exchange.
2. We received approval to stay halted until we completed the $1,220,000 private placement, which we did last Friday. No one expected it to take so long but COVID-19 disrupted everyone’s plans.
3. The Company actually benefited overall from the pandemic, which you will read about, but briefly we had more access to cardiologist and received a lot of government support (like many other companies). This allowed us to make major changes to almost every aspect of the VMS+3.0 to lower the barrier to adoption, reduce manufacturing costs, accelerate analysis and rewrite the entire source code. The key initiatives attachment is a long read (5 pages), but worth the time.
4. The major advantage of all this work is we no longer have to go to a hospital to install the machine, calibrate the probes and train the staff. It is all done remotely now. You will read about all the advantages this approach has created for us and our customers.
5. The hospitals, while focused on COVID, did continue in their processes to acquire a VMS+3.0 and so we have 11 major hospitals ready to acquire a system as soon as they re-open their echo labs. This is starting to happen as hospitals have to start dealing with regular cardiac patients.
6. We now know COVID wrecks havoc with the heart, especially the right side, and so cardiologists are very interested in our capabilities as they fear the heart problems induced by COVID could go on for decades.
7. Lots more news to come and lots more information on what we have been doing and why it is important on our revamped website and in the addendum..
8. We are in the final stages of the TSXV Exchange review to allow us to resume trading and so I expect that will happen very soon.
I am very thankful for all the people who encouraged me to keep going. It has not been a lot of fun, but we are in a very good place right now - a way ahead of where we were before we restructured. Our team has done remarkable things in the last 9 months and the responses we are seeing from cardiologists are reflecting that we have finally gotten through all the barriers to adoption with a device that is user-friendly and fits perfectly into the workflow of an echocardiography lab. I look forward to telling you all about the wonderful effects doctors with the VMS+3.0 are having on their patients, as well as how well the company is progressing to build value for its shareholders.
As usual, I thank you for your support and interest and if you have any questions or comments, email, text, call.
Regards,
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
Recent VPTDF News
- Shares Of AI Company Surging On FDA 510(k) Clearance News • AllPennyStocks.com • 02/27/2025 05:55:00 PM
- News Brief: Ventripoint Diagnostics Ltd. • AllPennyStocks.com • 11/20/2024 02:10:00 AM
- Will Shares Rise on Milestone Development for AI-Powered Heart Technology? • AllPennyStocks.com • 05/06/2024 01:50:00 PM
4Cable TV International, Inc. To Change Name to Opus Holdings, Inc. Set to Launch New Business Model with Potential Shareholder Dividends and a Fresh Leadership Team • CATV • Mar 25, 2025 8:30 AM
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform • AVAI • Mar 25, 2025 8:00 AM
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant • HLYK • Mar 24, 2025 8:00 AM
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • LFLRF • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM